Target intelligence / Profile preview

Solid Tumor Antigen (STA)

Target
STA
Molecular classification
Protein, Glycoprotein
01

Overview

Solid tumor antigen refers collectively to molecular markers exploited as therapeutic targets across diverse types of non-blood cancers. Most current clinical strategies focus on TAAs rather than truly unique TSAs due to their broader applicability despite increased safety concerns stemming from shared expression with some healthy tissues.

Other names
Tumor-Associated AntigenTumor-Specific AntigenTAATSA
02

Mechanism of action

Targeted cell killing via immune response or cytotoxic drug delivery

03

Biological functions

Immune recognitionCell signalingCell proliferationCell survivalAngiogenesis
04

Disease associations

Cancer
05

Safety considerations

Off-target toxicityOn-target/off-tumor toxicityCytokine release syndrome (CRS)NeurotoxicityTumor heterogeneityAntigen sheddingLimited therapeutic window
06

Interacting drugs

CAR-T cells

3 more in the full profile.

07

Biomarkers

HER2 expression levelEGFR expression levelPSMA expression levelCEA expression levelMUC1 expression levelGD2 expression levelMesothelin expression levelTROP2 expression level

Beyond the preview

Go deeper on Solid Tumor Antigen (STA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solid Tumor Antigen (STA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call